MedTrace Logo

Efficacy of Soluble Dexamethasone in Refractory Sciatica

NCT05000658 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2024-02-01

No results posted yet for this study

Summary

This is a phase 3 prospective randomised double-blind study versus placebo, measuring the efficacy of soluble Dexamethasone by echo-guided infiltrations through the sacro-coccygeal hiatus in intractable sciatica

Conditions

  • Sciatica

Interventions

DRUG

Dexamethasone phosphate

HSC injection of 4mL

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Maugars · Nantes University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-16
Primary Completion
2023-03-15
Completion
2023-03-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05000658 on ClinicalTrials.gov